PEStore

Buyout PE

Vinci Partners

Vinci Partners acquires controlling stakes in established, profitable businesses, from Brazil. It states a focus on healthcare & life sciences, financial services, education and consumer & retail.

Disclosed holdings17
Earliest stated investment2023
HeadquartersBrazil
Stated fund sizeR$ 16 billion

Stated investment criteria

What Vinci Partners says it buys

Read from Vinci Partners’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Transaction typesGrowth, Distressed1

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Vinci Partners states that it takes majority or outright ownership. Nothing here is a commitment by Vinci Partners to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How Vinci Partners is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusSEC registered
Regulatory assets under management$327m
Employees14
SEC adviser numberCRD 162399

Portfolio

Disclosed holdings

Companies Vinci Partners lists on its own website. 3 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Arklok20233
Bold Hospitality Company20242
AGV Logistics20251
Agribusiness
Argentina
Brazil
Brazil Credit
Capital Solutions
Corporate Advisory
Equities
Forestry
Hedge Fund
Infrastructure
Latam Credit
REAL ESTATE
Third Party Distribution
Vincipartners

Compiled from Vinci Partners’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Vinci Partners?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.